This paper describes the structure-activity relationships of a new class of
cytomegalovirus DNA polymerase inhibitors having two aryl groups joined by
an acyloxyamidine linker. Examination of a series of analogues in which th
e terminal groups are varied revealed a very narrow SAR around the 2,4-dich
lorophenyl group of the lead compound, but a variety of replacements for th
e benzothiazole ring are compatible with activity. The most notable of thes
e is the isoxazole ring of compound 78, which provides a 30-fold enhancemen
t in potency compared to the lead compound. We also describe the design, sy
nthesis and evaluation of 10 analogues in which the acyloxyamidine linker i
s modified or replaced by an isosteric group. Structure-activity relationsh
ip studies identified the linker -NH2 group as a critical pharmacophoric el
ement. Ab initio molecular orbital calculations combined with qualitative e
stimates of steric interaction energies suggest that the lowest energy conf
ormations of the acyloxyamidine linker are characterized by an extended pla
nar C-Ar-C=N-O-C arrangement and either a syn-periplanar or anti-periplanar
N-O-C-C-Ar, arrangement. Only the anti-periplanar conformation was observe
d in the crystal structures of three acyloxyamidines. The most active of th
e linker-modified compounds designed on the basis of these studies is the a
midine carbamate 20, which is approximately one-third as potent in the cyto
megalovirus DNA polymerase inhibition assay as the comparator acyloxyamidin
e 53, The activity of 20 suggests that acyloxyamidines may bind to the cyto
megalovirus DNA polymerase via an anti-periplanar conformation similar to t
hat observed in the crystal structure of acyloxyamidine 36. (C) 2000 Elsevi
er Science Ltd. All rights reserved.